-The Times of India NEW DELHI: Pharma companies may have to cough up huge penalties for unethical and illegal practices like offering freebies, gifts and foreign trips to doctors for pushing the sales of their products. The government is set to make mandatory the uniform code of conduct for pharmaceutical marketing practices, which have so far been voluntary. The department of pharmaceuticals (DoP) is working on a draft which will curb unethical...

-The Times of India MUMBAI: For the first time ever, some of India's biggest pharmaceutical companies, cutting across their respective associations and representing nearly half the Rs 93,000 crore market, have come together to push for ethical marketing practices to clean up the industry's image. The forum, comprising of 40 to 50 domestic and MNC firms, had its first closed-door meeting on October 14. It has made a "voluntary and moral commitment"...

-Outlook Scientist and longtime activist against genetically modified BT seeds, Dr. Vandana Shiva, talks about why BT has a devastating fallout. A sudden pest attack has ruined cotton crops in large parts of Punjab, bringing biotech, or BT Cotton back into focus. Farmers who used bio-fertilisers in the Malwa region of the state are said to be safe from this latest pestilence. But those growing BT cotton have lost everything. There...

-Down to Earth India’s public spending on health is among the lowest in South East Asia and BRIC countries The burden of aspirations and expectations seems to be taking a toll on young India, especially males who succumb to suicidal deaths more than their female counterparts, according to the data published by the Central Bureau of Health Intelligence (CBHI). The data showed that over 67 per cent cases of suicidal deaths in...

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...